Related Experiment Video
Updated: Jul 14, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
[Prevention and treatment of postoperative nausea and vomiting in children. An evidence-based approach]
1Service d'anesthésiologie, hôpitaux universitaires de Genève, Genève, Switzerland. martin.tramer@hcuge.ch <martin.tramer@hcuge.ch>
Insights
Effective postoperative nausea and vomiting (PONV) control now uses a "rule of three" approach. This involves identifying at-risk patients, optimizing anesthesia, and rationally combining antiemetics for better outcomes.
Area of Science:
- Anesthesiology
- Pharmacology
Context:
- Postoperative nausea and vomiting (PONV) remains a significant challenge in patient recovery.
- Recent advancements have improved the efficacy of PONV management strategies.
Purpose:
- To outline a pragmatic, evidence-based approach for controlling postoperative nausea and vomiting.
- To highlight current understanding of antiemetic efficacy, risks, and combination therapies.
Summary:
- The
- rule of three
- guides PONV management: identify high-risk patients, minimize baseline risk through anesthesia modification, and rationally administer combined antiemetics.
- Key antiemetic classes include butyrophenones, 5-HT(3) receptor antagonists, and steroids like dexamethasone.
- While individual antiemetics have limitations, combination therapy enhances efficacy.
Impact:
- Provides a structured framework for clinicians to optimize PONV prevention and treatment.
- Identifies critical areas for future research, particularly the need for more pediatric PONV data.
- Contributes to improved patient comfort and reduced complications following surgical procedures.
Abstract:
Significant improvement towards an efficacious control of postoperative nausea and vomiting (PONV) has taken place recently. These improvements may be summarised using the "rule of three". That rule describes a pragmatic and rational approach of PONV control. First, identify the patient at risk using predictive factors. Second, modify the anaesthesia technique to keep the baseline risk as low as possible. Third, administer antiemetics rationally, considering their degree of efficacy, their risk, and their potential additive effects. Despite considerable research efforts, identifying the patient at high risk of PONV remains a difficult task. However, today, we understand the degree of efficacy, dose-responsiveness, and adverse effects of most antiemetics. None of those molecules should be regarded as being universally efficacious, there is no gold standard, and, when used alone, their degree of efficacy is limited. Thus, they should be combined for improved efficacy. Among the most promising molecules are butyrophenones (droperidol, haloperidol), 5-HT(3) receptor antagonists (ondansetron, dolasetron, tropisetron, granisetron), and steroids (for instance, dexamethasone). The lack of relevant paediatric PONV data remains a major drawback and is highly unsatisfactory. Hopefully, future research will further improve the control of PONV not only in adults but also in children.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Pathophysiology of Vomiting
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
